GSK Drops as RSV Shot Suffers Fresh Blow With US Recommendation

GSK Drops as RSV Shot Suffers Fresh Blow With US RecommendationH&M Profit Misses as Summer Collections Fail to Lure ShoppersChina to Hold Delayed Party Meeting on Reform From July 15 to 18UK Patients Get Access to One of World’s Most Expensive DrugsTop Lobbyist Sees London Gaining Edge With France, US ElectionsNew World Tells Investors It Will Try to Pay Perp Bond Next YearBillionaire Birla’s UltraTech to Acquire 23% in India CementsIndian Financiers’ Debt Lures Buyers on Widest Spread...

Now 16 Million Thames Water Users are Picking Up the BillNumber of US Kids Has Fallen Since Pandemic, Except in FloridaNorth Korea Claims Success in Test for Multiple Warhead MissileMajority of Thais Back Plan to Label Cannabis as Narcotics AgainEx-Trump Associate Felix Sater Loses NY Money-Laundering TrialKenya President Bends to Pressure, Scraps $2.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GSK Plunges as Drugmaker Must Face Zantac Cases in DelawareGSK Plc shares slumped in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

GSK blood cancer drug nearly halves risk of death in late-stage trialExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »